Literature DB >> 8955052

A neutralization site of DA strain of Theiler's murine encephalomyelitis virus important for disease phenotype.

S Sato1, L Zhang, J Kim, J Jakob, R A Grant, R Wollmann, R P Roos.   

Abstract

DA strain of TMEV induces a chronic, persistent, demyelinating disease in SJL/J weanling mice, while inoculation with GDVII strain of TMEV induces an acute, lethal neurovirulent disease. We show that three amino acids in the DA EF loop-DAV P2 141 Lys, 143 Gly, and 173 Thr-are part of a neutralization site of DA monoclonal antibody (mAb), DAmAb1. DA virus with a mutation of VP2 143 from Gly to Asp, like wild-type virus, persists 6 weeks postinfection (PI) and produces white matter disease. DA virus with a mutation of VP2 141 from Lys to Asn persists but does not induce significant white matter disease. DA virus with a mutation of DA VP2 173 from Thr to Phe fails to persist or to induce significant white matter disease. The diversity and complexity of the mutant virus-induced disease phenotype presumably reflects the varied effects of the mutated amino acid residues on the three-dimensional structure of the viral capsid. The localization of DA VP2 141 and VP2 173 near the putative receptor binding region of the virus suggest that a disruption of interactions between the virus and its receptor is important in the late demyelinating disease and for virus neutralization.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8955052     DOI: 10.1006/viro.1996.0660

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  14 in total

1.  Analysis of cellular mutants resistant to Theiler's virus infection: differential infection of L929 cells by persistent and neurovirulent strains.

Authors:  K Jnaoui; T Michiels
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

2.  Sialylation of the host receptor may modulate entry of demyelinating persistent Theiler's virus.

Authors:  L Zhou; Y Luo; Y Wu; J Tsao; M Luo
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

3.  The neurovirulence of the DA and GDVII strains of Theiler's virus correlates with their ability To infect cultured neurons.

Authors:  N Jarousse; S Syan; C Martinat; M Brahic
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

4.  A CD8 T-cell epitope variant enhances immune targeting to a recombinant picornavirus vaccine antigen.

Authors:  Michael P Bell; Danielle N Renner; Aaron J Johnson; Kevin D Pavelko
Journal:  Viral Immunol       Date:  2014-07-15       Impact factor: 2.257

5.  Prolonged gray matter disease without demyelination caused by Theiler's murine encephalomyelitis virus with a mutation in VP2 puff B.

Authors:  I Tsunoda; Y Wada; J E Libbey; T S Cannon; F G Whitby; R S Fujinami
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

6.  Theiler's viruses with mutations in loop I of VP1 lead to altered tropism and pathogenesis.

Authors:  I J McCright; I Tsunoda; F G Whitby; R S Fujinami
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

7.  Mutations that affect the tropism of DA and GDVII strains of Theiler's virus in vitro influence sialic acid binding and pathogenicity.

Authors:  Karima Jnaoui; Muriel Minet; Thomas Michiels
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

Review 8.  Theiler's virus infection: a model for multiple sclerosis.

Authors:  Emilia L Oleszak; J Robert Chang; Herman Friedman; Christos D Katsetos; Chris D Platsoucas
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

9.  TGF-beta1 suppresses T cell infiltration and VP2 puff B mutation enhances apoptosis in acute polioencephalitis induced by Theiler's virus.

Authors:  Ikuo Tsunoda; Jane E Libbey; Robert S Fujinami
Journal:  J Neuroimmunol       Date:  2007-09-04       Impact factor: 3.478

Review 10.  Evolution of cell recognition by viruses: a source of biological novelty with medical implications.

Authors:  Eric Baranowski; Carmen M Ruiz-Jarabo; Nonia Pariente; Nuria Verdaguer; Esteban Domingo
Journal:  Adv Virus Res       Date:  2003       Impact factor: 9.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.